Consonance Capital Partners Closes Fund at $1.35 Billion
The New York-based investment firm reached its hard cap for its third private equity fund in under four months.
Updated on Oct. 16, 2026 in Healthcare
Live Poll
Do you trust private equity firms to manage healthcare investments for long-term patient and provider benefit?
Consonance Capital Partners successfully closed its Consonance Private Equity III fund with $1.35 billion in total commitments. The firm hit its hard cap after a fundraising process that lasted less than four months.
Why it matters
The firm intends to deploy this capital toward lower- and middle-market healthcare companies across the United States. Its strategy focuses on supporting businesses that aim to improve clinical efficiency, contain costs, and deliver high-quality care.
The firm secured $1.35 billion in capital commitments, hitting its hard cap in a rapid fundraising period of under four months.
The players
Consonance Capital Partners
This New York-based private equity firm specializes in investments within the healthcare sector.
Monument Group
This organization served as the global placement agent for the fundraise.
Latham & Watkins
This law firm provided the necessary legal counsel to finalize the transaction.
The details
The strategy for the new fund includes a wide range of investment types such as growth equity, leveraged buyouts, carve-outs, and recapitalizations. Investors participating in this round include endowments, foundations, pension plans, and financial institutions.
Timeline
Fundraising for the new capital began in June 2026.
The fund reached its final closing on October 16, 2026.
Market Landscape
This successful fund closing reflects the broader trend of rising institutional interest in private equity within the U.S. healthcare sector. It positions Consonance Capital Partners to continue scaling its investment presence against competitors in the middle-market space.
While this capital raise is a corporate event, it signals increased investment and potential expansion for the healthcare companies the firm eventually acquires. Average patients may see shifts in the service delivery models of companies backed by this fund as they pursue greater efficiency.
The takeaway
Private equity firms continue to prioritize healthcare targets that offer clear pathways to cost containment and operational efficiency. Investors should watch for increased M&A activity in the U.S. healthcare mid-market as this new capital is deployed.
Further reading
For additional context on local industry developments, read more in our New York City Healthcare section.
Source note: This article includes information reported by Hedgeco.
Live Poll
Do you trust private equity firms to manage healthcare investments for long-term patient and provider benefit?
